Figure 2.

Comparison of single-crystal and protein-bound structures of ALK inhibitors. (a) Protein-bound acyclic ligand in PDB entry 4cnh. (b) Small-molecule cyclic compound structure with CSD Refcode ZOJLIV. (c) Protein-bound cyclic ligand in PDB entry 4cli.